211 related articles for article (PubMed ID: 27474073)
21. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
[TBL] [Abstract][Full Text] [Related]
22. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.
Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897
[TBL] [Abstract][Full Text] [Related]
23. Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
Nascimento LS; de Castro YS; Figueira JA; Souza RDC; da Silva JA; Nahn EP; Peixoto-Rangel AL
PLoS One; 2024; 19(6):e0300704. PubMed ID: 38865430
[TBL] [Abstract][Full Text] [Related]
24. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
Foss NT; de Oliveira EB; Silva CL
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
[TBL] [Abstract][Full Text] [Related]
25. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
[TBL] [Abstract][Full Text] [Related]
26. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
27. Expression of B7-1 costimulatory molecules in patients with multibacillary leprosy and reactional states.
Santos DO; Castro HC; Bourguignon SC; Bastos OM; Rodrigues CR; Van Heuverswyn H; Nery JA; Miranda A
Clin Exp Dermatol; 2007 Jan; 32(1):75-80. PubMed ID: 17305909
[TBL] [Abstract][Full Text] [Related]
28. Critical residues of the Mycobacterium leprae LSR recombinant protein discriminate clinical activity in erythema nodosum leprosum reactions.
Singh S; Jenner PJ; Narayan NP; Ramu G; Colston MJ; Prasad HK; Nath I
Infect Immun; 1994 Dec; 62(12):5702-5. PubMed ID: 7525491
[TBL] [Abstract][Full Text] [Related]
29. Serologic recognition of low molecular weight mycobacterial protein fractions in lepromatous patients with type II reactions (ENL).
Rada EM; Zambrano EA; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):222-5. PubMed ID: 16830648
[No Abstract] [Full Text] [Related]
30. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
Suryawati N; Saputra H
Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
[TBL] [Abstract][Full Text] [Related]
31. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
[TBL] [Abstract][Full Text] [Related]
32. The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.
Nath I; Vemuri N; Reddi AL; Jain S; Brooks P; Colston MJ; Misra RS; Ramesh V
Immunol Lett; 2000 Dec; 75(1):69-76. PubMed ID: 11163869
[TBL] [Abstract][Full Text] [Related]
33. [Histopathologic findings for the research of acid-fast bacilli in erythema nodosum].
Pires MC; Calux Mde J; Valente NY
Rev Saude Publica; 1996 Dec; 30(6):536-41. PubMed ID: 9302823
[TBL] [Abstract][Full Text] [Related]
34. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
35. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
36. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
[TBL] [Abstract][Full Text] [Related]
37. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.
Moraes MO; Sampaio EP; Nery JA; Saraiva BC; Alvarenga FB; Sarno EN
Br J Dermatol; 2001 Jan; 144(1):175-81. PubMed ID: 11167702
[TBL] [Abstract][Full Text] [Related]
38. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
39. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
40. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
